Neurocrine Biosciences | Capitalisation Boursière



Market Capitalization Changement Date
AbbVie USD 347.08B 19.2B 2025-08
Acadia Pharmaceuticals USD 4.09B 483M 2025-08
Agios Pharmaceuticals USD 2B 66M 2025-08
ALKERMES USD 4.3B 422M 2025-08
Alnylam Pharmaceuticals USD 53.03B 10.5B 2025-08
Amgen USD 154.93B 4.8B 2025-08
Biogen USD 19.23B 818M 2025-08
BioMarin Pharmaceutical USD 10.92B 378M 2025-08
Cytokinetics USD 4.03B 80M 2025-08
Dynavax Technologies USD 1.36B 167M 2025-08
Exelixis USD 10.64B 1.94B 2025-08
Gilead Sciences USD 147.49B 9.58B 2025-08
Halozyme Therapeutics USD 7.99B 1.58B 2025-08
Incyte USD 17.01B 3.83B 2025-08
Ionis Pharmaceuticals USD 6.2B 94M 2025-08
Neurocrine Biosciences USD 12.83B 388M 2025-08
Pfizer USD 139.98B 2.45B 2025-08
Prothena USD 426M 99M 2025-08
Regeneron Pharmaceuticals USD 62.39B 6.52B 2025-08
Repligen USD 6.51B 474M 2025-08
Sarepta Therapeutics USD 1.71B 30M 2025-08
Teva Pharmaceutical Industries ILS 59.94B 5.42B 2025-08
Ultragenyx Pharmaceutical USD 2.27B 1.17B 2025-08
Vertex Pharmaceuticals USD 97.65B 16.68B 2025-08


Neurocrine Biosciences Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.